Aleafia Health Is Positioned To Explode After Completing Its Acquisition of Emblem Cannabis

Last month, we highlighted Aleafia Health (ALEF.V) (ALEAF) as a leading Canadian cannabis opportunity that was flying under the radar. We have been closely watching this burgeoning cannabis company and believe that recent developments make this a company that investors need to be watching.

Aleafia Health Funded Study Finds Increase in Employment Among Epileptic Medical Cannabis Patients

Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH), announced the results of a 4,000 medical cannabis patient study examining changes in employment and disability status among medical cannabis patients. The study was published on March 13, 2019 in the peer-reviewed Journal of Drug Issues, and is, to the Company and author’s knowledge, the first to ever directly observe physician-led medical cannabis usage and labour force status over time.

3 Ancillary Cannabis Companies Aggressively Scaling Their Footprint

During the last year, we have seen an increase in the number of companies that are levered to the cannabis industry but do not touch the actual plant. Some of these ancillary cannabis companies represent legitimate opportunities and are capitalizing on underserved markets within the cannabis industry.

Isracann Presents Investors With A Unique International Investment Opportunity

In 1964, Israeli scientists Raphael Mechoulam of the Hebrew University in Jerusalem's Center for Research on Pain and Yechiel Gaoni of the Weizmann Institute made history by becoming the first to isolate Tetrahydrocannabinol (THC), the psychoactive chemical component in cannabis.